MATINAS BIOPHARMA HOLDINGS, INC. Earnings Per Share, Basic and Diluted
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Earnings Per Share, Basic and Diluted of -$0.11 per share for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-11
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.03.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.03.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.02.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.03.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.11.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.12.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.13.
- MATINAS BIOPHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.15.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.06 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.11 10-K/A · filed 2022-03-11 | |
| 2021-09-30 | -$0.03 10-Q · filed 2021-11-08 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-11-02 | -$0.08 10-Q · filed 2021-11-08 | -$0.11 derived: net income ÷ weighted average shares · filed 2022-11-02 | |
| 2021-06-30 | -$0.02 10-Q · filed 2021-08-10 | -$0.05 10-Q · filed 2021-08-10 | -$0.08 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$0.11 derived: net income ÷ weighted average shares · filed 2022-08-11 | |
| 2021-03-31 | -$0.03 10-Q · filed 2021-05-10 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$0.12 derived: net income ÷ weighted average shares · filed 2022-05-12 | |
| 2020-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-03-11 | -$0.12 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | -$0.03 10-Q · filed 2021-11-08 | -$0.06 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$0.09 10-Q · filed 2021-11-08 | -$0.12 derived: net income ÷ weighted average shares · filed 2021-11-08 | |
| 2020-06-30 | -$0.03 10-Q · filed 2021-08-10 | -$0.06 10-Q · filed 2021-08-10 | -$0.09 derived: net income ÷ weighted average shares · filed 2021-08-10 | -$0.12 derived: net income ÷ weighted average shares · filed 2021-08-10 | |
| 2020-03-31 | -$0.03 10-Q · filed 2021-05-10 | -$0.06 derived: net income ÷ weighted average shares · filed 2021-05-10 | -$0.09 derived: net income ÷ weighted average shares · filed 2021-05-10 | -$0.12 derived: net income ÷ weighted average shares · filed 2021-05-10 | |
| 2019-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$0.06 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$0.09 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$0.13 10-K · filed 2021-03-29 | |
| 2019-09-30 | -$0.03 10-Q · filed 2020-11-06 | -$0.05 derived: net income ÷ weighted average shares · filed 2020-11-06 | -$0.09 10-Q · filed 2020-11-06 | -$0.12 derived: net income ÷ weighted average shares · filed 2020-11-06 | |
| 2019-06-30 | -$0.03 10-Q · filed 2020-08-10 | -$0.06 10-Q · filed 2020-08-10 | -$0.10 derived: net income ÷ weighted average shares · filed 2020-08-10 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-08-10 | |
| 2019-03-31 | -$0.04 10-Q · filed 2020-05-11 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$0.11 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$0.14 derived: net income ÷ weighted average shares · filed 2020-05-11 | |
| 2018-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.11 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.15 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$0.03 10-Q · filed 2019-11-13 | -$0.07 derived: net income ÷ weighted average shares · filed 2019-11-13 | -$0.12 10-Q · filed 2019-11-13 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-11-13 | |
| 2018-06-30 | -$0.04 10-Q · filed 2019-08-13 | -$0.08 10-Q · filed 2019-08-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-08-13 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-08-13 | |
| 2018-03-31 | -$0.05 10-Q · filed 2019-05-13 | -$0.09 derived: net income ÷ weighted average shares · filed 2019-05-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-05-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2019-05-13 | |
| 2017-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2019-04-01 | -$0.08 derived: net income ÷ weighted average shares · filed 2019-04-01 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-04-01 | -$0.36 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$0.04 10-Q · filed 2018-11-09 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-11-09 | -$0.32 10-Q · filed 2018-11-09 | -$0.33 10-Q · filed 2017-11-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2018-11-09 |
| 2017-06-30 | -$0.04 10-Q · filed 2018-08-09 | -$0.29 10-Q · filed 2018-08-09 | -$0.35 derived: net income ÷ weighted average shares · filed 2018-08-09 | -$0.46 derived: net income ÷ weighted average shares · filed 2018-08-09 | |
| 2017-03-31 | -$0.25 10-Q · filed 2018-05-09 | -$0.33 derived: net income ÷ weighted average shares · filed 2018-05-09 | -$0.44 derived: net income ÷ weighted average shares · filed 2018-05-09 | -$0.48 derived: net income ÷ weighted average shares · filed 2018-05-09 | |
| 2016-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.14 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.21 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$0.11 10-Q · filed 2017-11-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$0.18 10-Q · filed 2017-11-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-03-16 | |
| 2016-06-30 | -$0.03 10-Q · filed 2017-08-08 | -$0.07 10-Q · filed 2017-08-08 | -$0.10 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.14 derived: net income ÷ weighted average shares · filed 2018-03-16 | |
| 2016-03-31 | -$0.04 10-Q · filed 2017-05-15 | -$0.07 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.11 derived: net income ÷ weighted average shares · filed 2018-03-16 | ||
| 2015-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.07 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.18 10-K · filed 2018-03-16 | ||
| 2015-09-30 | -$0.04 10-Q · filed 2016-11-14 | -$0.14 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | -$0.04 10-Q · filed 2016-08-15 | -$0.11 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | -$0.07 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | -$0.32 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | -$0.08 10-Q · filed 2015-11-10 | -$0.22 10-Q · filed 2015-11-10 | |||
| 2014-06-30 | -$0.08 10-Q · filed 2015-08-13 | -$0.14 10-Q · filed 2015-08-13 | |||
| 2014-03-31 | -$0.07 10-Q · filed 2015-05-15 | ||||
| 2013-12-31 | -$0.20 10-K · filed 2015-03-31 | ||||
| 2013-09-30 | -$0.10 10-Q · filed 2014-11-14 | -$0.13 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$0.03 10-Q · filed 2014-08-08 | -$0.05 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | -$0.01 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |